Notably, the identification and validation of specific proteins such as SAA1, SAA4, VCAM1, and LRG1 underscores their potential as biomarkers for distinguishing iCCA from HCC, as well as from PSC. This evidence concerns the gene SAA4 and hepatocellular carcinoma.